Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2012
10/03/2012CN102698250A Injection for alcoholic liver and fatty liver
10/03/2012CN102698249A Injection for treating encephalatrophy
10/03/2012CN102698248A Medicine composition prepared from alanyl glutamine and compound amino acid by utilizing spray drying method
10/03/2012CN102698247A Glutamine dipeptide and compound amino acid medicinal composition prepared with solvent crystallization method
10/03/2012CN102698246A Antihypertensive drug of enalapril and safflower oil nanoemulsion
10/03/2012CN102698245A Antihypertensive drug of quinapril hydrochloride and rose oil nanoemulsion
10/03/2012CN102698244A Drug composition used for preventing piglets from diarrhea and promoting piglets to grow
10/03/2012CN102698243A Preparation method of extract capable of absorbing harmful metal in body
10/03/2012CN102697809A Preparation method of in-vitro anti-gosling-plague transfer factors
10/03/2012CN102697808A In-vitro preparation method of transfer factors capable of resisting duck viral hepatitis
10/03/2012CN102210856B Collagen eye drops and preparation method thereof
10/03/2012CN102199584B Antithrombotic enzyme Eupolytinl from Eupolyphaga sinensis Walker and gene and application thereof
10/03/2012CN102133236B Toad peptide antibiotics for preparing medicine for curing lung cancer
10/03/2012CN102100687B Application of medicine composition with function of exterminating oral helicobacter pylori
10/03/2012CN102061291B Lysozyme as well as preparation and application thereof
10/03/2012CN102051348B Humanized recombinant uricase and mutant thereof
10/03/2012CN101897956B External use recombinant human neuropeptide Y nanoemulsion and preparation method thereof
10/03/2012CN101891823B Exendin-4 and analog fusion protein thereof
10/03/2012CN101857634B Activator protein for fibrinolytic system
10/03/2012CN101848723B Bacteriocin inducer peptides
10/03/2012CN101798338B Application of anti-opioid peptide antagonist peptide
10/03/2012CN101671390B Human interferon alpha derivatives and preparation and use of pegylated products thereof
10/03/2012CN101668778B Preparation of low bleeding anticoagulant fusion protein and its use
10/03/2012CN101642565B Method for preparing oxygen carrier freeze-dried preparation of haemoglobin
10/03/2012CN101580535B Hcv protease inhibitors
10/03/2012CN101518646B Lipase-containing composition
10/03/2012CN101516375B Combinations of class-I specific histone deacetylase inhibitors with proteasome inhibitors
10/03/2012CN101466386B Augmentation of titer for vaccination in animals
10/03/2012CN101365471B Effect of bri proteins on abeta production
10/03/2012CN101284874B Peptide-based immunization therapy for treatment of atherosclerosis
10/03/2012CN101067135B Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents
10/03/2012CN101011574B Use of an anti-il6 receptor antibody for preparing pharmaceutical composition
10/03/2012CN101001670B Compositions for sleeping disorders
10/02/2012US8278430 Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012US8278417 Kits for treating wounds
10/02/2012US8278414 DNA sequence encoding a retinoic acid regulated protein
10/02/2012US8278413 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
10/02/2012US8278412 Polypeptide, nucleic acid molecule encoding it and their uses
10/02/2012US8278332 Photostabilization of retinoids with alkoxycrylene compounds
10/02/2012US8278322 HCV NS3 protease inhibitors
10/02/2012US8278286 Use of gp130 activators in diabetic neuropathy
10/02/2012US8278280 Antagonists of the bradykinin B1 receptor
10/02/2012US8278279 Method for treating prostatitis utilizing modified pore-forming protein proaerolysin
10/02/2012US8278278 Cell proliferation reducing cancer specific PCNA peptides
10/02/2012US8278277 Delivery of hydrophilic drugs
10/02/2012US8278276 Methods of treating autism
10/02/2012US8278275 Method to enhance hemodynamic stability using oxygen carrying compositions
10/02/2012US8278274 Fibrin-binding peptides and conjugates thereof
10/02/2012US8278273 Methods of enhancing functioning of the large intestine
10/02/2012US8278272 GLP-1, exendin-4, peptide analogs and uses thereof
10/02/2012US8278271 Inhibiting collagen-induced platelet aggregation and activation with peptide variants
10/02/2012US8278270 HGF precursor protein variant and active protein thereof
10/02/2012US8278269 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine
10/02/2012US8278268 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
10/02/2012US8278267 Method of modifying food preference comprising administering amylin or amylin agonist
10/02/2012US8278266 Inhibition of migration and induction of cell death by the type II collagen amino propeptides
10/02/2012US8278265 Methods, kits and compositions comprising crotamine
10/02/2012US8278264 Compositions and methods for enhancing drug delivery across and into ocular tissues
10/02/2012US8278263 Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase D and raptor
10/02/2012US8278262 Use of microproteins as tryptase inhibitors
10/02/2012US8278103 Oligonucleotides comprising alternating segments and uses thereof
10/02/2012US8278098 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/02/2012US8278081 Method for producing non-infectious products from infectious organic waste material
10/02/2012US8278046 Methods for testing milk
10/02/2012US8278042 Compositions and methods for the diagnosis and treatment of tumor
10/02/2012US8277847 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
10/02/2012US8277846 Complexing agents for compositions containing inclusion complexes
10/02/2012US8277837 Hemostatic textile
10/02/2012US8277822 Botulinum toxin treatment
10/02/2012US8277820 Process for preparing variant of Erysipelothrix rhusiopathiae surface protective antigen in E. coli
10/02/2012US8277818 Herpes virus strains for gene therapy
10/02/2012US8277817 PEGylation by the dock and lock (DNL) technique
10/02/2012US8277815 Pharmaceutical composition comprising an antigen
10/02/2012US8277814 Avian Astrovirus
10/02/2012US8277813 Tick salivary polypeptide for use in generating vaccine for prevention and treatment of blood borne infection; immunotherapy
10/02/2012US8277800 Methods of treating a deficiency of functional tripeptidyl peptidase I (CLN2) protein
10/02/2012US8277793 Prophylactic or therapeutic agent for viral disease
10/02/2012US8277792 Peptides for active anti-cytokine immunization
10/02/2012US8277440 Implantable device for controlled, extended delivery of parathyroid hormone
10/02/2012US8277436 Advancing distal portion of catheter to existing blood vessel and releasing medicant
10/02/2012CA2711007C G-csf analog compositions and methods
10/02/2012CA2669457C Calcium-containing structures and methods of making and using the same
10/02/2012CA2552266C Continuous method for producing bioactive molecule coated particles, bioactive molecule coated particles and uses therefor
10/02/2012CA2502848C Use of irl-1620 and paclitaxel for preventing and treating breast tumors
10/02/2012CA2487779C P53 binding t cell receptor molecules and uses thereof
10/02/2012CA2478111C A cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy
10/02/2012CA2427477C Active variants of fgf with improved specificity
10/02/2012CA2417874C Use of ox-2 inhibitors for the treatment of cancer
10/02/2012CA2394676C Tyrosine- and tryptophan-containing peptides as antioxidants
10/02/2012CA2332733C Signal peptides, nucleic acid molecules and methods for treatment of caries
10/02/2012CA2309003C Insect cells or fractions as adjuvant for antigens
10/02/2012CA2223269C Hepatocyte growth factor receptor antagonists and uses thereof
10/02/2012CA2208841C High molecular weight polymer-based prodrugs
10/02/2012CA2133306C Amplification of human mdm2 gene in human tumors
09/2012
09/27/2012WO2012129519A1 Formulations of diluted amino acid segments and methods for making same
09/27/2012WO2012129513A2 Blockage of pai-1 in diabetic cd34+ stem cells corrects cellular dysfunction
09/27/2012WO2012129493A1 Vancomycin derivatives
09/27/2012WO2012129473A1 Gallium complexes, pharmaceutical compositions and methods of use
09/27/2012WO2012129448A1 Methods and compositions for improving antiangiogenic therapy with anti-integrins
1 ... 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 ... 3163